Company intelligence / Profile preview

Dachien

Ownership: Private
Development stage: Other

Overview

DACHI BIOTECH CO., LIMITED is a private biotechnology company based in Hong Kong SAR, China, founded in 2019. The company operates in the biomedical sector. As of November 2024, there are no publicly available details about its drug pipeline, clinical results, or technology platforms. No patents or deals have been posted publicly. The company's focus appears to be within life sciences and healthcare but specifics regarding products or research areas are not disclosed.

Industry: Biotech

Beyond the preview

Go deeper on Dachien.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dachien.

Explore the full profile